Allowing patients with cancer to pay for their own drug treatment may bring extra resources into the UK

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.346, 2002-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Willingness to Pay for Lung Cancer Treatment

By Lang Hui-Chu  

Value in Health, Vol. 13, Iss. 6, 2010-09 ,pp. : 743-749

Blackwell Publishing

Access to resources Recommend Favorite

UK govt tackles drug prices, provides extra anticancer funding

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 614, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Despite limitations, therapeutic drug monitoring may be of value in antiretroviral treatment in HIV-infected patients

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 7, 2005-07 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Patients with advanced gastric cancer may benefit from treatment with a combination of capecitabine and docetaxel

By  

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

More drug information required by UK patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 425, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite